Clinical Trial Update: A Study for Teriparatide in Severe Osteoporosis

View source ↗

Summary

A completed clinical trial evaluating teriparatide for severe osteoporosis has finished, sponsored by Eli Lilly and Company.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis
• Postmenopausal Osteoporosis

Drugs mentioned

• Teriparatide (Teriparatide)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Osteoporosis, Postmenopausal, Osteoporosis | Status: COMPLETED